BD, a Franklin Lakes, N.J.-based medical technology company, recently unveiled the BD Veritor Plus System, a wireless diagnostic device that can detect influenza A and B, respiratory syncytial virus and group A strep.
The device produces results within minutes, allowing clinicians to discuss diagnosis and treatment methods in one consultation session.
The next generation device can document user ID, specimen ID and test kit lot number to ensure accurate traceability. The device also allows clinicians to wirelessly transfer test data to an EMR or laboratory information system in a secure manner.
"As we are on the cusp of the flu season, it is critical that providers have the diagnostic tools they need to assist them in quickly and accurately identifying infectious diseases, like flu, RSV and strep and in assigning treatment protocols," said Dave Hickey, BD's president of diagnostic systems. "The BD Veritor Plus System's ability to provide reliable test results and wirelessly transfer them to health records could ultimately lead to better outcomes through rapid detection and simplified workflow."
More articles on supply chain:
Trucking volumes rebound in August
Sarepta plans to sell $225M of stock to support clinical trials, drug commercialization
Negotiated price of Medicare Hep C treatments lower than countries with set pricing system